Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aastrom awarded second NIH grant to develop production system for UCB stem cells

Nov. 3, 1998

ArQule, Roche Bioscience amend R&D agreement

Nov. 3, 1998

Targeted Genetics receives patent coverage for cellular therapy platform

Nov. 2, 1998

Senetek licenses autoinjectable drug delivery system to ICN

Oct. 29, 1998

IDEA licenses drug delivery technology to Procter & Gamble

Oct. 28, 1998

CE Mark approval granted for AastromReplicell system components

Oct. 28, 1998

Baxter, Inhale will seek partner to continue development of drug candidate

Oct. 28, 1998

ThromboSol prolongs cryopreservation of rhTPO-stimulated platelets in in vitro study

Oct. 27, 1998

Phase I studies establish feasibility, tolerability of oral delivery of heparin

Oct. 26, 1998

Endorex/Elan joint venture to develop Medipad-based drugs

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...